Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Beyer

Showing results (151-160 of 225) with videos related to

Pageof 23
Sort By:
Optics Express|June 11, 2024
Wide-range resistivity characterization of semiconductors with terahertz time-domain spectroscopyJoshua Hennig, Jens Klier, Stefan Duran, et al.
Thrombosis and Haemostasis|February 8, 2019
Determinants of the Quality of Warfarin Control after Venous Thromboembolism and Validation of the SAMe-TT2-R2 Score: An Analysis of Hokusai-VTEStefano Barco, Serena Granziera, Michiel Coppens, et al.
Optics Express|December 19, 2025
Simultaneous charge carrier density mapping of SiC epilayers and substrates with terahertz time-domain spectroscopyJoshua Hennig, Jens Klier, Stefan Duran, et al.
International Journal of Cardiology|November 16, 2016
Major bleeding with vitamin K antagonists or direct oral anticoagulants in real-lifeCecilia Becattini, Laura Franco, Jan Beyer-Westendorf, et al.
Thrombosis and Haemostasis|December 1, 2012
Efficacy and safety of thromboprophylaxis with low-molecular-weight heparin or rivaroxaban in hip and knee replacement surgery: findings from the ORTHO-TEP registryJan Beyer-Westendorf, Jörg Lützner, Lars Donath, et al.
Blood|May 27, 2014
Rates, management, and outcome of rivaroxaban bleeding in daily care: results from the Dresden NOAC registryJan Beyer-Westendorf, Kati Förster, Sven Pannach, et al.
Thrombosis Research|July 31, 2021
Patient-reported outcomes associated with changing to rivaroxaban for the treatment of cancer-associated venous thromboembolism - The COSIMO studyAlexander T Cohen, Anthony Maraveyas, Jan Beyer-Westendorf, et al.
Thrombosis and Haemostasis|September 3, 2020
Anticoagulation Treatment in Cancer-Associated Venous Thromboembolism: Assessment of Patient Preferences Using a Discrete Choice Experiment (COSIMO Study)Nils Picker, Agnes Y Lee, Alexander T Cohen, et al.
The Oncologist|April 14, 2018
Use of Direct Oral Anticoagulants in Patients with Cancer: Practical Considerations for the Management of Patients with Nausea or VomitingHanno Riess, Cihan Ay, Rupert Bauersachs, et al.
Thrombosis and Haemostasis|May 4, 2021
SARS-CoV-2 Vaccine and Thrombosis: An Expert Consensus on Vaccine-Induced Immune Thrombotic ThrombocytopeniaIsmail Elalamy, Grigoris Gerotziafas, Sonia Alamowitch, et al.
Pageof 23

Showing results (151-160 of 225) with videos related to

Sort By:
Pageof 23
Optics Express|June 11, 2024
Wide-range resistivity characterization of semiconductors with terahertz time-domain spectroscopyJoshua Hennig, Jens Klier, Stefan Duran, et al.
Thrombosis and Haemostasis|February 8, 2019
Determinants of the Quality of Warfarin Control after Venous Thromboembolism and Validation of the SAMe-TT2-R2 Score: An Analysis of Hokusai-VTEStefano Barco, Serena Granziera, Michiel Coppens, et al.
Optics Express|December 19, 2025
Simultaneous charge carrier density mapping of SiC epilayers and substrates with terahertz time-domain spectroscopyJoshua Hennig, Jens Klier, Stefan Duran, et al.
International Journal of Cardiology|November 16, 2016
Major bleeding with vitamin K antagonists or direct oral anticoagulants in real-lifeCecilia Becattini, Laura Franco, Jan Beyer-Westendorf, et al.
Thrombosis and Haemostasis|December 1, 2012
Efficacy and safety of thromboprophylaxis with low-molecular-weight heparin or rivaroxaban in hip and knee replacement surgery: findings from the ORTHO-TEP registryJan Beyer-Westendorf, Jörg Lützner, Lars Donath, et al.
Blood|May 27, 2014
Rates, management, and outcome of rivaroxaban bleeding in daily care: results from the Dresden NOAC registryJan Beyer-Westendorf, Kati Förster, Sven Pannach, et al.
Thrombosis Research|July 31, 2021
Patient-reported outcomes associated with changing to rivaroxaban for the treatment of cancer-associated venous thromboembolism - The COSIMO studyAlexander T Cohen, Anthony Maraveyas, Jan Beyer-Westendorf, et al.
Thrombosis and Haemostasis|September 3, 2020
Anticoagulation Treatment in Cancer-Associated Venous Thromboembolism: Assessment of Patient Preferences Using a Discrete Choice Experiment (COSIMO Study)Nils Picker, Agnes Y Lee, Alexander T Cohen, et al.
The Oncologist|April 14, 2018
Use of Direct Oral Anticoagulants in Patients with Cancer: Practical Considerations for the Management of Patients with Nausea or VomitingHanno Riess, Cihan Ay, Rupert Bauersachs, et al.
Thrombosis and Haemostasis|May 4, 2021
SARS-CoV-2 Vaccine and Thrombosis: An Expert Consensus on Vaccine-Induced Immune Thrombotic ThrombocytopeniaIsmail Elalamy, Grigoris Gerotziafas, Sonia Alamowitch, et al.
Pageof 23